These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35749295)

  • 21. Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19.
    Boccardi V
    Nat Rev Endocrinol; 2021 Mar; 17(3):189. PubMed ID: 33452491
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of COVID-19 Pandemic on Pediatric Diabetes Mellitus.
    Shin CH
    J Korean Med Sci; 2022 Jun; 37(22):e186. PubMed ID: 35668690
    [No Abstract]   [Full Text] [Related]  

  • 23. Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
    Wise J
    BMJ; 2022 Jul; 378():o1838. PubMed ID: 35868645
    [No Abstract]   [Full Text] [Related]  

  • 24. Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice.
    International Society of Pediatric and Adolescent Diabetes (ISPAD)
    Pediatr Diabetes; 2020 May; 21(3):413-414. PubMed ID: 32346988
    [No Abstract]   [Full Text] [Related]  

  • 25. The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions.
    Yaribeygi H; Sathyapalan T; Jamialahmadi T; Sahebkar A
    J Diabetes Res; 2020; 2020():5436832. PubMed ID: 33294461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Does having diabetes increase chances of contracting COVID-19 infection?".
    Gangopadhyay KK
    Diabetes Metab Syndr; 2020; 14(5):765-766. PubMed ID: 32512520
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes Mellitus and COVID-19: Unholy Association of Two Pandemics.
    Kamrul-Hasan AB; Nessa A; Debnath CR
    Mymensingh Med J; 2021 Jan; 30(1):1-2. PubMed ID: 33397842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes after SARS-CoV-2 infection.
    Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Jan; 11(1):11-13. PubMed ID: 36463908
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetes and COVID-19; a Review of Possible Mechanisms.
    Moradi-Marjaneh R; Asgharzadeh F; Khordad E; Marjaneh MM
    Curr Pharm Des; 2021; 27(21):2522-2527. PubMed ID: 33655850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Virtual Inpatient Diabetes Management Service: COVID-19 brings the future to inpatient diabetes management.
    Cheung NW; Hor A; Hng TM
    Med J Aust; 2022 Apr; 216(6):321-322. PubMed ID: 35267199
    [No Abstract]   [Full Text] [Related]  

  • 31. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?
    Pal R; Banerjee M
    Prim Care Diabetes; 2021 Feb; 15(1):18-20. PubMed ID: 32800450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
    Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
    Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
    Singh AK; Singh R
    Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic β-cell fate in subjects with COVID-19.
    Shirakawa J
    J Diabetes Investig; 2021 Dec; 12(12):2126-2128. PubMed ID: 34529355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of diabetes mellitus in the clinical course and outcome of SARS-CoV-2 infected patients.
    Maltezou HC; Pavli A; Tsonou P; Balaska A; Raftopoulos V; Papadima K; Andreopoulou A; Tentolouris A; Gamaletsou MN; Sipsas NV; Tentolouris N
    Hormones (Athens); 2022 Jun; 21(2):221-227. PubMed ID: 35138606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 in People with Diabetes: Perspectives from Saudi Arabia.
    Robert AA; Al Dawish MA
    Curr Diabetes Rev; 2021; 17(6):e111020187810. PubMed ID: 33176657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The COVID-19 pandemic may be receding but the diabetes pandemic rages on.
    Mulder H; Fall T
    Diabetologia; 2022 Jun; 65(6):915-916. PubMed ID: 35294579
    [No Abstract]   [Full Text] [Related]  

  • 39. The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.
    McGovern AP; Thomas NJ; Vollmer SJ; Hattersley AT; Mateen BA; Dennis JM
    Diabetologia; 2021 May; 64(5):1184-1186. PubMed ID: 33594475
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.
    Abbasi-Oshaghi E; Mirzaei F; Khodadadi I
    Prim Care Diabetes; 2021 Feb; 15(1):30. PubMed ID: 33162350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.